These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5525564)

  • 1. [Clinical aspects of hepato-lenticular degeneration].
    Fazio C; Agnoli A; Casacchia M
    Epatologia; 1970; 16(1):41-4. PubMed ID: 5525564
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of hepatolenticular degeneration. Study of the "turnover" of copper in some extrapyramidal syndromes].
    Agnoli A; Casacchia M; Fieschi C
    Recenti Prog Med; 1970 Oct; 49(4):385-98. PubMed ID: 5537615
    [No Abstract]   [Full Text] [Related]  

  • 3. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 4. [Copper metabolism in hepato-lenticular degeneration thiol therapy].
    KONOVALOV NV; MUTTEL'SHTEDT AA; BAUMAN LK; GOTOVTSEVA EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1957; 57(1):39-48. PubMed ID: 13434449
    [No Abstract]   [Full Text] [Related]  

  • 5. [Wilson's disease (hepatolenticular degeneration)].
    Bickel H
    Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
    [No Abstract]   [Full Text] [Related]  

  • 6. [Postural dystonia and spastic torticollis associated with an increase of cupriuria. Relations with hepato-lenticular degeneration].
    Fazio C; Agnoli A; Perissinotti E
    Minerva Med; 1968 Aug; 59(63):3359-68. PubMed ID: 5679202
    [No Abstract]   [Full Text] [Related]  

  • 7. The story of penicillamine: a difficult birth.
    Walshe JM
    Mov Disord; 2003 Aug; 18(8):853-9. PubMed ID: 12889074
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepato-lenticular degeneration. (Case report and review of literature).
    Arora OP; Jain KP; Sobti P
    J Assoc Physicians India; 1967 Feb; 15(2):79-82. PubMed ID: 6045123
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiopathology of hepatolenticular degeneration (Wilson's disease)].
    Willvonseder R
    Wien Z Inn Med; 1973; 54(11-12):544-58. PubMed ID: 4804125
    [No Abstract]   [Full Text] [Related]  

  • 10. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 11. Uncommon EEG findings in hepato-lenticular degeneration.
    Mera A
    Electroencephalogr Clin Neurophysiol; 1969 Aug; 27(2):218. PubMed ID: 4184189
    [No Abstract]   [Full Text] [Related]  

  • 12. The intrahepatic distribution of copper in relation to the pathogenesis of hepatolenticular degeneration.
    UZMAN LL
    AMA Arch Pathol; 1957 Oct; 64(4):464-79. PubMed ID: 13457604
    [No Abstract]   [Full Text] [Related]  

  • 13. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 14. The development of cirrhosis in Wilson's disease.
    Sternlieb I
    Clin Gastroenterol; 1975 May; 4(2):367-79. PubMed ID: 1092490
    [No Abstract]   [Full Text] [Related]  

  • 15. [Wilson's disease. Hepatic manifestations].
    Oliveira e Silva A; Roldan Molina LF; dos Santos TE; Santo GC; Gama-Rodrigues JJ; D'Albuquerque LA
    Arq Gastroenterol; 1989; 26(3):47-9. PubMed ID: 2697201
    [No Abstract]   [Full Text] [Related]  

  • 16. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
    Smithgall JM
    J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765
    [No Abstract]   [Full Text] [Related]  

  • 17. [Copper metabolism: ultimate therapeutic implications in cholestasis].
    Thierman-Duffaud D; Lévy VG
    Med Chir Dig; 1981; 10(4):331-2. PubMed ID: 7300488
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereotypies in Wilson's disease.
    Yorio AA; Mesri JC; Pagano MA; Lera G
    Mov Disord; 1997 Jul; 12(4):614-6. PubMed ID: 9251089
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.